Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling ...
Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy recommendation. Analyst Price Forecast Suggests 7.56% Upside As of March 19, 2025, ...
Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...
The most recent lawsuit is from winter 2024, when the California attorney general announced a $5 million settlement with ...
In a report released today, David S Macdonald from Truist Financial maintained a Hold rating on Quest Diagnostics (DGX – Research Report). The company’s shares closed yesterday at $168.01. Easily ...
(RTTNews) - Quest Diagnostics (DGX) reaffirmed its guidance for full year 2025. The company continues to project: adjusted EPS in a range of $9.55 to $9.80, and net revenues in a range of $10.70 ...
Fans of the beleaguered retail chain Big Lots will be happy to learn that the first locations to reopen after its bankruptcy last year are currently undergoing a cleaning, remodeling, and re ...